BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30376374)

  • 21. Significant Variability in the Identification and Reporting of Band Neutrophils by Participants Enrolled in the College of American Pathologists Proficiency Testing Program: Time for a Change.
    Vergara-Lluri M; Kovach AE; Nakashima MO; Bradley KT; Mahe E; Tsao L; Savage NM; Salansky SA; Long T; Perkins SL; Hsi ED; Pozdnyakova O; Bhargava P
    Arch Pathol Lab Med; 2024 Jun; 148(6):666-676. PubMed ID: 37638547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. External Quality Assurance of Platelet Function Assays: Results of the College of American Pathologists Proficiency Testing Program.
    Chandler WL; Brown AF; Chen D; Moser K; Olson JD; Pham HP; Smock KJ; Volod O; Higgins RA
    Arch Pathol Lab Med; 2019 Apr; 143(4):472-482. PubMed ID: 30920864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists.
    Jennings LJ; Arcila ME; Corless C; Kamel-Reid S; Lubin IM; Pfeifer J; Temple-Smolkin RL; Voelkerding KV; Nikiforova MN
    J Mol Diagn; 2017 May; 19(3):341-365. PubMed ID: 28341590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing.
    Zhong Q; Wagner U; Kurt H; Molinari F; Cathomas G; Komminoth P; Barman-Aksözen J; Schneider-Yin X; Rey JP; Vassella E; Rogel U; Diebold J; McKee T; Jochum W; Kashofer K; Hofman P; Zischka M; Moch H; Rechsteiner M; Wild PJ
    Pathol Res Pract; 2018 Jul; 214(7):957-963. PubMed ID: 29807778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Marked Variability in Reported Minimal Residual Disease Lower Level of Detection of 4 Hematolymphoid Neoplasms: A Survey of Participants in the College of American Pathologists Flow Cytometry Proficiency Testing Program.
    Keeney M; Halley JG; Rhoads DD; Ansari MQ; Kussick SJ; Karlon WJ; Mehta KU; Dorfman DM; Linden MA
    Arch Pathol Lab Med; 2015 Oct; 139(10):1276-80. PubMed ID: 25695342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Estrogen and Progesterone Receptor Antibody Reagents Using Proficiency Testing Data.
    Troxell ML; Long T; Hornick JL; Ambaye AB; Jensen KC
    Arch Pathol Lab Med; 2017 Oct; 141(10):1402-1412. PubMed ID: 28714765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. External Quality Assurance of Current Technology for the Testing of Cancer-Associated Circulating Free DNA Variants.
    Chai SY; Peng R; Zhang R; Zhou L; Pillay N; Tay KH; Badrick T; Li J; Horan MP
    Pathol Oncol Res; 2020 Jul; 26(3):1595-1603. PubMed ID: 31487000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer.
    Garcia EP; Minkovsky A; Jia Y; Ducar MD; Shivdasani P; Gong X; Ligon AH; Sholl LM; Kuo FC; MacConaill LE; Lindeman NI; Dong F
    Arch Pathol Lab Med; 2017 Jun; 141(6):751-758. PubMed ID: 28557599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory compliance with the American Society of Clinical Oncology/college of American Pathologists guidelines for human epidermal growth factor receptor 2 testing: a College of American Pathologists survey of 757 laboratories.
    Nakhleh RE; Grimm EE; Idowu MO; Souers RJ; Fitzgibbons PL
    Arch Pathol Lab Med; 2010 May; 134(5):728-34. PubMed ID: 20441503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Laboratory-Developed Tests and FDA-Approved Assays for BRAF, EGFR, and KRAS Testing.
    Kim AS; Bartley AN; Bridge JA; Kamel-Reid S; Lazar AJ; Lindeman NI; Long TA; Merker JD; Rai AJ; Rimm DL; Rothberg PG; Vasalos P; Moncur JT
    JAMA Oncol; 2018 Jun; 4(6):838-841. PubMed ID: 29242895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Trichomonas vaginalis in different Papanicolaou test preparations: trends over time in the College of American Pathologists educational Interlaboratory Comparison Program.
    Howell LP; Darragh TM; Souers RJ; Thomas N; Moriarty AT
    Arch Pathol Lab Med; 2013 Aug; 137(8):1043-6. PubMed ID: 23899059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proficiency Testing of Virus Diagnostics Based on Bioinformatics Analysis of Simulated
    Brinkmann A; Andrusch A; Belka A; Wylezich C; Höper D; Pohlmann A; Nordahl Petersen T; Lucas P; Blanchard Y; Papa A; Melidou A; Oude Munnink BB; Matthijnssens J; Deboutte W; Ellis RJ; Hansmann F; Baumgärtner W; van der Vries E; Osterhaus A; Camma C; Mangone I; Lorusso A; Marcacci M; Nunes A; Pinto M; Borges V; Kroneman A; Schmitz D; Corman VM; Drosten C; Jones TC; Hendriksen RS; Aarestrup FM; Koopmans M; Beer M; Nitsche A
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Somatic Curation and Interpretation Across Laboratories (SOCIAL) project-current state of solid-tumour variant interpretation for molecular pathology in Canada.
    Spence T; Sukhai MA; Kamel-Reid S; Stockley TL
    Curr Oncol; 2019 Dec; 26(6):353-360. PubMed ID: 31896933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of the UK NEQAS for Molecular Genetics reference sample analysis.
    Richman SD; Fairley J; Hall JA; Nataraj N; Bhide M; Lau A; Norman KL; Deans ZC
    J Clin Pathol; 2018 Nov; 71(11):989-994. PubMed ID: 30030291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. College of American Pathologists' laboratory standards for next-generation sequencing clinical tests.
    Aziz N; Zhao Q; Bry L; Driscoll DK; Funke B; Gibson JS; Grody WW; Hegde MR; Hoeltge GA; Leonard DG; Merker JD; Nagarajan R; Palicki LA; Robetorye RS; Schrijver I; Weck KE; Voelkerding KV
    Arch Pathol Lab Med; 2015 Apr; 139(4):481-93. PubMed ID: 25152313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.
    Li MM; Datto M; Duncavage EJ; Kulkarni S; Lindeman NI; Roy S; Tsimberidou AM; Vnencak-Jones CL; Wolff DJ; Younes A; Nikiforova MN
    J Mol Diagn; 2017 Jan; 19(1):4-23. PubMed ID: 27993330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laboratory compliance with the American Society of Clinical Oncology/College of American Pathologists human epidermal growth factor receptor 2 testing guidelines: a 3-year comparison of validation procedures.
    Dyhdalo KS; Fitzgibbons PL; Goldsmith JD; Souers RJ; Nakhleh RE
    Arch Pathol Lab Med; 2014 Jul; 138(7):876-84. PubMed ID: 24978913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variability in Testing for Antineutrophil Cytoplasmic Antibodies: A Survey of Participants in the College of American Pathologists Proficiency Testing Program.
    Karlon WJ; Naides SJ; Crosson JT; Ansari MQ
    Arch Pathol Lab Med; 2016 Jun; 140(6):524-8. PubMed ID: 27232346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility testing of Mycobacterium avium complex in clinical laboratories. Results of a questionnaire and proficiency test performance by participants in the College of American Pathologists Mycobacteriology E Survey.
    Woods GL; Witebsky FG
    Arch Pathol Lab Med; 1996 May; 120(5):436-9. PubMed ID: 8639045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analytical performance evaluation of a commercial next generation sequencing liquid biopsy platform using plasma ctDNA, reference standards, and synthetic serial dilution samples derived from normal plasma.
    Verma S; Moore MW; Ringler R; Ghosal A; Horvath K; Naef T; Anvari S; Cotter PD; Gunn S
    BMC Cancer; 2020 Oct; 20(1):945. PubMed ID: 33004033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.